Neuroimaging Methods for Adolescent Substance Use Disorder Prevention Science

被引:8
|
作者
Clark, D. B. [1 ,2 ,3 ]
Chung, T. [1 ]
Pajtek, S. [1 ]
Zhai, Z. [2 ]
Long, E. [1 ]
Hasler, B. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA
[3] Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA
关键词
Adolescents; Neuroimaging; Substance use disorders; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GRAY-MATTER VOLUME; WHITE-MATTER; SEROTONIN TRANSPORTER; PSYCHOLOGICAL DYSREGULATION; 5-HTTLPR POLYMORPHISM; RESPONSE-INHIBITION; HIPPOCAMPAL VOLUME; EXECUTIVE FUNCTION; GREY-MATTER;
D O I
10.1007/s11121-012-0323-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Magnetic resonance imaging (MRI) methods safely provide in vivo indicators of cerebral macrostructure, microstructure, and activation that can be examined in relation to substance use disorder (SUD) risks and effects. This article will provide an overview of MRI approaches, including volumetric measures, diffusion tensor imaging, and functional MRI, that have been applied to studies of adolescent neuromaturation in relationship to risk phenotypes and adolescent SUD. To illustrate these applications, examples of research findings will be presented. MRI indicators have demonstrated that neurobiological maturation continues throughout adolescence. MRI research has suggested that variations in neurobiological maturation may contribute to SUD risk, and that substance use adversely influences adolescent brain development. Directly measured neurobiological variables may be viable preventive intervention targets and outcome indicators. Further research is needed to provide definitive findings on neurodevelopmental immaturity as an SUD risk and to determine the directions such observations suggest for advancing prevention science.
引用
收藏
页码:300 / 309
页数:10
相关论文
共 50 条
  • [1] Neuroimaging Methods for Adolescent Substance Use Disorder Prevention Science
    D. B. Clark
    T. Chung
    S. Pajtek
    Z. Zhai
    E. Long
    B. Hasler
    Prevention Science, 2013, 14 : 300 - 309
  • [2] Adolescent Substance Use Disorder
    Karns, Michelle
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2018, 14 (05): : A13 - A14
  • [3] Neuroimaging the Effectiveness of Substance Use Disorder Treatments
    Cabrera, Elizabeth A.
    Wiers, Corinde E.
    Lindgren, Elsa
    Miller, Gregg
    Volkow, Nora D.
    Wang, Gene-Jack
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 (03) : 408 - 433
  • [4] Neuroimaging the Effectiveness of Substance Use Disorder Treatments
    Elizabeth A. Cabrera
    Corinde E. Wiers
    Elsa Lindgren
    Gregg Miller
    Nora D. Volkow
    Gene-Jack Wang
    Journal of Neuroimmune Pharmacology, 2016, 11 : 408 - 433
  • [5] Behavioral Science and the Prevention of Adolescent Substance Abuse
    Biglan, Anthony
    Van Ryzin, Mark J.
    PERSPECTIVES ON BEHAVIOR SCIENCE, 2019, 42 (03) : 547 - 563
  • [6] Behavioral Science and the Prevention of Adolescent Substance Abuse
    Anthony Biglan
    Mark J. Van Ryzin
    Perspectives on Behavior Science, 2019, 42 : 547 - 563
  • [7] Adolescent Substance Use and the Brain: Behavioral, Cognitive and Neuroimaging Correlates
    Hamidullah, Shahnaza
    Thorpe, Hayley H. A.
    Frie, Jude A.
    Mccurdy, Richard D.
    Khokhar, Jibran Y.
    FRONTIERS IN HUMAN NEUROSCIENCE, 2020, 14
  • [8] New Dimensions for Adolescent Substance Use Prevention
    Tortolero, Susan R.
    JOURNAL OF PRIMARY PREVENTION, 2012, 33 (5-6): : 223 - 224
  • [9] New Dimensions for Adolescent Substance Use Prevention
    Susan R. Tortolero
    The Journal of Primary Prevention, 2012, 33 : 223 - 224
  • [10] Motivational treatmetn of an adolescent with a substance use disorder
    Kuestner, Udo J.
    Baldus, Christiane
    PSYCHOTHERAPEUT, 2009, 54 (03): : 205 - 209